Comentarios Editoriales
Fármacos anti-TNF, anticuerpos antinucleares y autoinmunidad en pacientes con psoriasis
Tumor Necrosis Factor Inhibitors, Antinuclear Antibodies, and Autoimmunity in Patients With Psoriasis
P. de la Cueva Dobao
Servicio de Dermatología, Hospital Universitario Infanta Leonor, Madrid, España
Leído
7297
Vecesse ha leído el artículo
2046
Total PDF
5251
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 55 | 55 | 110 |
| 2025 5 | 126 | 36 | 162 |
| 2025 4 | 135 | 24 | 159 |
| 2025 3 | 175 | 15 | 190 |
| 2025 2 | 167 | 36 | 203 |
| 2025 1 | 157 | 31 | 188 |
| 2024 12 | 143 | 27 | 170 |
| 2024 11 | 129 | 64 | 193 |
| 2024 10 | 156 | 35 | 191 |
| 2024 9 | 114 | 26 | 140 |
| 2024 8 | 110 | 58 | 168 |
| 2024 7 | 127 | 35 | 162 |
| 2024 6 | 119 | 32 | 151 |
| 2024 5 | 66 | 36 | 102 |
| 2024 4 | 95 | 25 | 120 |
| 2024 3 | 84 | 35 | 119 |
| 2024 2 | 99 | 43 | 142 |
| 2024 1 | 100 | 29 | 129 |
| 2023 12 | 94 | 16 | 110 |
| 2023 11 | 104 | 33 | 137 |
| 2023 10 | 64 | 28 | 92 |
| 2023 9 | 58 | 30 | 88 |
| 2023 8 | 74 | 13 | 87 |
| 2023 7 | 102 | 35 | 137 |
| 2023 6 | 65 | 29 | 94 |
| 2023 5 | 89 | 22 | 111 |
| 2023 4 | 55 | 21 | 76 |
| 2023 3 | 77 | 17 | 94 |
| 2023 2 | 66 | 24 | 90 |
| 2022 1 | 83 | 18 | 101 |
| 2022 12 | 55 | 35 | 90 |
| 2022 11 | 72 | 29 | 101 |
| 2022 10 | 90 | 35 | 125 |
| 2022 9 | 53 | 45 | 98 |
| 2022 8 | 43 | 47 | 90 |
| 2022 7 | 59 | 45 | 104 |
| 2022 6 | 51 | 31 | 82 |
| 2022 5 | 40 | 32 | 72 |
| 2022 4 | 53 | 34 | 87 |
| 2022 3 | 44 | 37 | 81 |
| 2022 2 | 45 | 17 | 62 |
| 2021 1 | 58 | 40 | 98 |
| 2021 12 | 50 | 25 | 75 |
| 2021 11 | 54 | 33 | 87 |
| 2021 10 | 81 | 57 | 138 |
| 2021 9 | 51 | 28 | 79 |
| 2021 8 | 48 | 29 | 77 |
| 2021 7 | 42 | 30 | 72 |
| 2021 6 | 82 | 34 | 116 |
| 2021 5 | 53 | 31 | 84 |
| 2021 4 | 111 | 53 | 164 |
| 2021 3 | 104 | 43 | 147 |
| 2021 2 | 65 | 31 | 96 |
| 2020 1 | 45 | 26 | 71 |
| 2020 12 | 58 | 18 | 76 |
| 2020 11 | 63 | 24 | 87 |
| 2020 10 | 68 | 22 | 90 |
| 2020 9 | 71 | 26 | 97 |
| 2020 8 | 47 | 29 | 76 |
| 2020 7 | 50 | 17 | 67 |
| 2020 6 | 52 | 25 | 77 |
| 2020 5 | 58 | 19 | 77 |
| 2020 4 | 49 | 18 | 67 |
| 2020 3 | 32 | 9 | 41 |
| 2020 2 | 4 | 0 | 4 |
| 2020 1 | 4 | 0 | 4 |
| 2019 12 | 5 | 2 | 7 |
| 2019 11 | 4 | 0 | 4 |
| 2019 10 | 2 | 0 | 2 |
| 2019 9 | 4 | 0 | 4 |
| 2019 8 | 8 | 0 | 8 |
| 2019 7 | 4 | 0 | 4 |
| 2019 6 | 4 | 0 | 4 |
| 2019 5 | 5 | 2 | 7 |
| 2019 4 | 2 | 0 | 2 |
| 2019 3 | 1 | 2 | 3 |
| 2019 2 | 6 | 2 | 8 |
| 2019 1 | 3 | 2 | 5 |
| 2018 12 | 2 | 0 | 2 |
| 2018 11 | 3 | 2 | 5 |
| 2018 9 | 5 | 0 | 5 |
| 2018 7 | 1 | 0 | 1 |
| 2018 5 | 6 | 1 | 7 |
| 2018 4 | 1 | 2 | 3 |
| 2018 3 | 2 | 2 | 4 |
| 2018 2 | 6 | 2 | 8 |
| 2018 1 | 8 | 1 | 9 |
| 2017 12 | 4 | 3 | 7 |
| 2017 11 | 6 | 0 | 6 |
| 2017 10 | 1 | 0 | 1 |
| 2017 9 | 11 | 2 | 13 |
| 2017 8 | 4 | 1 | 5 |
| 2017 7 | 8 | 8 | 16 |
| 2017 6 | 42 | 19 | 61 |
| 2017 5 | 0 | 2 | 2 |
| 2017 4 | 0 | 4 | 4 |
| 2017 3 | 0 | 5 | 5 |
Mostrar todo
